Schemathesis vs Insomnia
Feature checklists rarely decide anything. What decides it is the pricing metric, who has to write the tests, and which limitation you can live with.
Entry price
Free tier available
Free tierFrom $12 per user/month (Pro; ~17% off billed annually)
Free tierWhat drives the bill
The metric that actually scales your invoice.
Open source. A commercial hosted service exists for reporting and continuous runs.
Free for small teams; Pro lifts the user cap and adds RBAC, and Enterprise at $45 per user/month adds SSO/SCIM and Kong Konnect integration.
Free tier
The CLI and Python library are open source and free.
Essentials is free for up to 3 users, including local and cloud projects, CLI and 1,000 mock requests a month.
Open source
MIT
Apache-2.0
Self-hostable
No-code authoring
Languages
Platforms
Fits teams
Adoption
Established
Schemathesis · since 2019
Widely used
Kong · since 2016
Strengths
- Enormous coverage for almost no authoring effort — the schema is the test suite.
- Reliably finds unhandled server errors and schema violations that manual tests miss.
- Failures come with a minimal reproducing case.
- Noticeably faster and lighter than Postman for everyday request work.
- Best-in-class GraphQL and gRPC ergonomics.
- Design-first OpenAPI workflow with linting built in.
Limitations
- Only as good as your schema; a vague or inaccurate spec produces noise.
- Tests conformance, not business correctness — it cannot know a discount was miscalculated.
- Generated failures can be tedious to triage at first.
- A forced-account change in 2023 damaged trust; check the current model before standardising on it.
- Test scripting is less capable than Postman's.
- Smaller ecosystem of shared collections.
Best for
Any team with an accurate OpenAPI spec who wants deep coverage cheaply.
Developers who mainly want a fast client with excellent GraphQL support.
All of these integrate with: GitHub Actions, OpenAPI, GraphQL.
Pricing last reviewed August 2026 and is indicative only — confirm on each vendor’s own page.